Funding Opportunities

• Zika Virus (ZIKV) Complications (R21)
  (PA-17-085)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Allergy and Infectious Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Eye Institute
  National Institute of Neurological Disorders and Stroke
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the NIDDK Repository (R01)
  (PAR-17-123)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Perception and Cognition Research to Inform Cancer Image Interpretation (R21)
  (PAR-17-124)
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): May 30, 2017; September 26, 2017; May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Perception and Cognition Research to Inform Cancer Image Interpretation (R01)
  (PAR-17-125)
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): May 30, 2017; September 26, 2017; May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
• Juvenile Protective Factors and Their Effects on Aging (R01)
  (PAR-17-126)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 5, 2017 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Juvenile Protective Factors and Their Effects on Aging (R03)
  (PAR-17-127)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 16, 2017. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3)
  (PAR-17-128)
  National Cancer Institute
  Application Receipt Date(s): May 9, 2017; September 12, 2017; January 9, 2018; May 9, 2018; September 12, 2018; January 9, 2019; May 9, 2019; September 12, 2019; January 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01)
  (PAR-17-129)
  National Cancer Institute
  Application Receipt Date(s): May 9, 2017; September 12, 2017; January 9, 2018; May 9, 2018; September 12, 2018; January 9, 2019; May 9, 2019; September 12, 2019; January 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)
  (RFA-HL-18-003)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): June 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Research Program Award (R35)
  (RFA-NS-17-020)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): March 21, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.